z-logo
Premium
The bee venom peptide tertiapin underlines the role of I KACh in acetylcholine‐induced atrioventricular blocks
Author(s) -
Drici MilouDaniel,
Diochot Sylvie,
Terrenoire Cécile,
Romey Georges,
Lazdunski Michel
Publication year - 2000
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0703611
Subject(s) - acetylcholine , chronotropic , medicine , atropine , anti arrhythmia agents , pharmacology , potassium channel , vagus nerve , cardiology , chemistry , heart rate , stimulation , atrial fibrillation , blood pressure
Acetylcholine (ACh) is an important neuromodulator of cardiac function that is released upon stimulation of the vagus nerve. Despite numerous reports on activation of I KACh by acetylcholine in cardiomyocytes, it has yet to be demonstrated what role this channel plays in cardiac conduction. We studied the effect of tertiapin, a bee venom peptide blocking I KACh , to evaluate the role of I KACh in Langendorff preparations challenged with ACh. ACh (0.5 μ M ) reproducibly and reversibly induced complete atrioventricular (AV) blocks in retroperfused guinea‐pig isolated hearts ( n =12). Tertiapin (10 to 300 n M ) dose‐dependently and reversibly prevented the AV conduction decrements and the complete blocks in unpaced hearts ( n =8, P <0.01). Tertiapin dose‐dependently blunted the ACh‐induced negative chronotropic response from an ACh‐induced decrease in heart rate of 39±16% in control conditions to 3±3% after 300 n M tertiapin ( P =0.01). These effects were not accompanied by any significant change in QT intervals. Tertiapin blocked I KACh with an IC 50 of 30±4 n M with no significant effect on the major currents classically associated with cardiac repolarisation process ( I Kr , I Ks , I to1 , I sus , I K1 or I KATP ) or AV conduction ( I Na and I Ca(L) ). In summary, tertiapin prevents dose‐dependently ACh‐induced AV blocks in mammalian hearts by inhibiting I KACh .British Journal of Pharmacology (2000) 131 , 569–577; doi: 10.1038/sj.bjp.0703611

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom